West pharmaceutical alert: bragar eagel & squire, p.c. announces that a class action lawsuit has been filed against west pharmaceutical services, inc. and encourages investors to contact the firm

New york, may 08, 2025 (globe newswire) -- bragar eagel & squire, p.c., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against west pharmaceutical services, inc. (“west pharmaceutical” or the “company”) (nyse:wst) in the united states district court for the eastern district of pennsylvania on behalf of all persons and entities who purchased or otherwise acquired west pharmaceutical securities between february 16, 2023, and february 12, 2025, both dates inclusive (the “class period”). investors have until july 7, 2025 to apply to the court to be appointed as lead plaintiff in the lawsuit.
WST Ratings Summary
WST Quant Ranking